Pfizer said on Thursday it completed an acquisition worth up to $10 billion of biotech firm Metsera after winning shareholder ...

Jay Lalezari, CEO of CytoDyn, explains how the CCR5 receptor has emerged as a pivotal target in metastatic cancers due to its ...

A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

A new study published in Biomedicine & Pharmacotherapy reports that a blend of cannabidiol (CBD) and cannabidivarin (CBDV) ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn ...

Until now, researchers assumed that schizophrenia, anxiety disorders or depression arise from an interplay of many different ...

Retatrutide is a powerful experimental weight loss drug that currently lacks FDA approval. Learn how it works, plus the legal and safety risks of buying retatrutide online.

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

GLP-1 medications silence "food noise" for many, but have high discontinuation rates and significant side effects. Is there a ...

Your eyes—retinal blood vessels and retinal imaging—may help predict heart disease, according to a new study. Here, doctors ...

New research reveals insomnia's deep links to cardiovascular health, urging us to treat it as a core medical issue, not a ...